As of December 2025 Karyopharm Therapeutics has a market cap of $0.10 Billion USD. This makes Karyopharm Therapeutics the world's 9263th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 8th, 2025 the market cap of Karyopharm Therapeutics was reported to be: